International Myeloma Workshop 2021 | Daily Update, Part 2 | CAR-T Cell Therapy + Smoldering MM

Did you find this video helpful? If so, please let us know via the survey below:
www.surveymonkey.com/r/MMRF20...
Mary DeRome, Director of Medical Communications and Education at the Multiple Myeloma Research Foundation, speaks with Dr. Irene Ghobrial, Lavine Family Chair of Preventative Cancer Therapy and Director of the Center for Prevention of Progression at the Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr. Cesar Rodriguez, Associate Professor of Medicine and Clinical Director for Multiple Myeloma at the Icahn School of Medicine at Mount Sinai Hospital in New York, New York.
Dr. Ghobrial and Dr. Rodriguez provide insights on the key takeaways for patients from the second day of presentations at the International Myeloma Workshop (IMW) 2021 meeting. These presentations focused on CAR T-cell therapy, bispecific antibodies, smoldering multiple myeloma, and COVID-19.
Daily updates from IMW 2021 are supported by GlaxoSmithKline, Janssen, Karyopharm, and Oncopeptides. Please visit the Virtual Exhibit Hall for more information from our sponsors. themmrf.org/resources/educati...
For more information on our patient education program and events please visit: themmrf.org/resources/educati...
If you have additional questions about what you watched, please call our MMRF Patient Navigation Center at 1-888-841-6673.

[@kvcooks814]

So wonderful to see and hear Dr. Ghobrial speak about the Promise study! I was a part of it and was found to have some precursor markers. I was able to be find a hematological oncologist that I really like, get (very) thoroughly tested and be more informed as to my risks. I have a date on my calendar to be re-checked in a year.

[@marilyncruz4]

Thanks!